# US 2021/0061855 A1 · Novel peptide

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2021/0061855 A1
- Document ID: US20210061855A1
- Status: Published application
- Kind: A1
- Application number: 16/956,754
- Filed: 2018-12-17
- Published: 2021-03-04
- Earliest claimed: 2017-12-28
- Assignees: Hysensbio
- Applicants: Hysensbio
- Inventors: Joo Hwang PARK; Ji-Hyun LEE
- Web page: https://patentgrep.com/patent/US20210061855A1

## CPC

- C07K 7/06: having 5 to 11 amino acids
- A23L 33/18: Peptides; Protein hydrolysates
- A61P 1/02: Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
- A23V 2002/00: Food compositions, function of food ingredients or processes for food or foodstuffs
- A23V 2200/312: having an effect on dental health
- A61K 38/00: Medicinal preparations containing peptides (peptides containing beta-lactam rings A61K31/00; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, A61K31/00; ergot alkaloids of the cyclic peptide type A61K31/48; containing macromolecular compounds having statistically distributed amino acid units A61K31/74; medicinal preparations containing antigens or antibodies A61K39/00; medicinal preparations characterised by the non-active ingredients, e.g. peptides as drug carriers, A61K47/00)
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)
- A23L: FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF (preservation thereof A23B)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A23V: INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)

## Abstract

A novel peptide and a composition including the peptide are disclosed. The composition may be a pharmaceutical composition, a quasi-drug composition, a dietary supplement, or a food composition. A polynucleotide encoding the peptide and an expression vector including the polynucleotide are also disclosed. The peptide promotes regeneration of hard tissue and is useful for treating dentin-dental pulp diseases or periodontal diseases.

## Claims

### Claim 1

A peptide consists of any one amino acid sequence of SEQ ID NOS: 1 to 128.

### Claim 2 (depends on 1)

The peptide of claim 1, wherein the peptide consists of any one amino acid sequence of SEQ ID NOS: 1 to 24.

### Claim 3 (depends on 1)

The peptide of claim 1, wherein the peptide consists of any one amino acid sequence of SEQ ID NOS: 25 to 48.

### Claim 4 (depends on 1)

The peptide of claim 1, wherein the peptide consists of any one amino acid sequence of SEQ ID NOS: 49 to 128.

### Claim 5 (depends on 1)

The peptide of claim 1, wherein the peptide is for promoting regeneration of hard tissue, and treating a dentin-dental pulp disease or periodontal disease.

### Claim 6 (depends on 1)

The peptide of claim 1, wherein the peptide has a modification selected from the group consisting of an N- or C-terminal acetylation, amidation, or methylation; a D-amino acid introduction; a peptide bond modification selected from the group consisting of CH2—NH, CH2—S, CH2—S=0, and CH2—CH2; a backbone modification; and a side-chain modification.

### Claim 7 (depends on 1)

A polynucleotide encoding the peptide of claim 1.

### Claim 8 (depends on 7)

An expression vector comprising the polynucleotide of claim 7.

### Claim 9 (depends on 1)

A method for promoting regeneration of hard tissue in a subject in need thereof, comprising administering the peptide of claim 1 to the subject.

### Claim 10 (depends on 1)

A method for treating dental-dentin pulp disease or periodontal disease in a subject in need thereof, comprising administering the peptide of claim 1 to the subject.

### Claim 11 (depends on 1)

A composition comprising the peptide of claim 1.

### Claim 12 (depends on 11)

The composition of claim 11, which is a pharmaceutical composition, a dietary supplement, or a foodstuff
